.png?width=150&name=MMS%20logo_without%20Tagline%20(Full%20Color).png "MMS logo_without Tagline (Full Color)")
Why You Should Update Your Clinical Trial Disclosure Policy for the EU Clinical Trials Regulation and ICMJE Requirements Now
By Karim Ibazatene, Associate Director, Transparency
Quality Control of Regulatory Documents: Best Practices to Ensure a First-Time Quality Approach
Abstract: The concept of regulatory document quality in the pharmaceutical industry derives, in part, from ...
MMS HOLDINGS JOINS DECENTRALIZED TRIALS & RESEARCH ALLIANCE (DTRA) AS A FOUNDING MEMBER TO ACCELERATE THE ADOPTION OF PATIENT-FOCUSED CLINICAL TRIALS
CANTON, Mich. (January 29, 2021) – MMS Holdings – an award-winning, data-focused CRO – joins a historic ...
MMS Academy Launches Mobile App for Accessing Pharmaceutical Industry Virtual Learning Courses from Anywhere
CANTON, Mich. (October 28, 2020) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today ...
FDA Advisory Committee Meeting Held to Discuss Important Topics Surrounding COVID-19 Vaccines
by Samantha Hoopes, PhD, RAC The US Food and Drug Administration’s (FDA) Vaccines and Related Biological ...
Modernizing the Functional Service Provider (FSP) Relationship: Innovations to bring value beyond “Global and Scalable”
Abstract: The Global Clinical Research Organization (CRO) market is expected to grow to $71.7 billion in ...
EY Announces Dr. Uma Sharma of MMS Holdings as an Entrepreneur Of The Year® 2020 Michigan and Northwest Ohio Award Finalist
Celebrating the unstoppable entrepreneurs whose ambitions transform our world CANTON, Mich. (August 31, 2020) ...
MichBio Invites MMS Founder and Chief Scientific Officer Dr. Uma Sharma to Join Board of Directors
CANTON, Mich. (August 28, 2020)– MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced ...
